AdvisorShares Investments LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1425930
BETHESDA, MD
Position in TEVA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,114,076
+$16,775 QoQ
Shares Held
32,883
-9.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#326
of 671 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $261,923,894 across 17 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CURLF |
Curaleaf Holdings, Inc.
|
12,420,961 | $134,270,588 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
10,641,152 | $104,602,524 | |
| 3 | GLAS |
Glass House Brands Inc.
|
850,000 | $11,050,000 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
11,553 | $1,947,142 | |
| 5 | ALKS |
Alkermes plc.
|
36,438 | $1,909,351 | |
| 6 | CRON |
Cronos Group Inc.
|
482,394 | $1,341,055 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,618 | $1,284,513 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
32,883 | $1,114,076 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,114,076 | 32,883 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,097,301 | 36,431 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,148,528 | 36,800 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $663,707 | 43,182 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $632,459 | 28,696 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $593,146 | 32,916 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||